See also this year's filing and all EDGAR filings for this company.
PDF Report 0001660334_2023_Verrica_Pharmaceuticals_Inc.pdf
Logs
Graph
Absolute values for 0001660334, Verrica Pharmaceuticals Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 39,115,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 3,887,000 |
| 3 | remainder_Assets | 1,719,000 |
| 4 | LiabilitiesCurrent | 3,459,000 |
| 5 | LiabilitiesNoncurrent | 1,229,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 17,405,000 |
| 9 | ResearchAndDevelopmentExpense | 12,198,000 |
| 10 | remainder_Expenses | 725,000 |
| 11 | remainder_Revenues | 9,032,000 |
| 12 | remainder_NetIncome | -3,191,000 |
| 13 | remainder_ComprehensiveNetIncome | 29,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 44,721,000 |
| 1 | Liabilities | 4,688,000 |
| 2 | Expenses | 30,328,000 |
| 3 | Revenues | 9,032,000 |
| 4 | StockholdersEquity | 40,033,000 |
| 5 | NetIncome | -24,487,000 |
| 6 | ComprehensiveNetIncome | -24,472,500 |
| 7 | BaseVar | 45,994,500 |
| 8 | EconomicCapitalRatio | 1.80 |
Edgar->Model Mapping
Feature Distribution
Change over Time
